Detection of CEA and ProGRP Levels in BALF of Patients with Peripheral Lung Cancer and Their Relationship with CT Signs
- PMID: 35937401
- PMCID: PMC9348922
- DOI: 10.1155/2022/4119912
Detection of CEA and ProGRP Levels in BALF of Patients with Peripheral Lung Cancer and Their Relationship with CT Signs
Retraction in
-
Retracted: Detection of CEA and ProGRP Levels in BALF of Patients with Peripheral Lung Cancer and Their Relationship with CT Signs.Biomed Res Int. 2023 Dec 29;2023:9810949. doi: 10.1155/2023/9810949. eCollection 2023. Biomed Res Int. 2023. PMID: 38188794 Free PMC article.
Abstract
Background: Lung cancer is a common clinical thoracic malignant tumor, which had a serious impact on the safety of patients, currently ranking first in all malignant tumors in morbidity and mortality, with generally less than 5% survival rate in 5 years.
Objective: To investigate the relationship and significance between carcinoembryonic antigen (CEA) and precursor gastrin-releasing peptide (ProGRP) changing levels in bronchoalveolar lavage fluid (BALF) and CT imaging features in patients with peripheral lung cancer.
Methods: A total of 90 patients diagnosed with peripheral lung cancer as the lung cancer group and 60 patients with benign lung diseases as the control group in our hospital from May 2019 to October 2021 were selected to compare the differences of CEA and ProGRP in BALF by the classification of CT features.
Results: The levels of CEA and ProGRP in the BALF of the lung cancer group were significantly higher than those of the control group; the proportion of patients with lobulation sign, burr sign, ground glass sign, pleural effusion, and lesion diameter ≥ 3.0 cm in the lung cancer group was higher than that in the control group; the CEA level in BALF of lung cancer patients with spicule sign, pleural effusion, and lesion diameter ≥ 3.0 cm was significantly higher than that without these symptoms, while ProGRP level in the BALF of lung cancer patients with lobulation sign, burr sign, ground glass sign, pleural effusion, and lesion diameter ≥ 3.0 cm was significantly higher than that of lung cancer patients without these symptoms.
Conclusion: The check of CEA and ProGRP in BALF in combination with CT features has a certain clinical value for the diagnosis of lung cancer. At the same time, the increased levels of CEA and ProGRP in BALF have a certain correlation with the changes of malignant signs of lung cancer in CT examination.
Copyright © 2022 Kui Tian et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures
Similar articles
-
Detection of Changes in CEA and ProGRP Levels in BALF of Patients with Peripheral Lung Cancer and the Relationship with CT Signs.Contrast Media Mol Imaging. 2023 Feb 18;2023:1421709. doi: 10.1155/2023/1421709. eCollection 2023. Contrast Media Mol Imaging. 2023. PMID: 36851977 Free PMC article.
-
[Value of tumor markers series of hydrothorax in differential diagnosis of pleural effusion].Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2008 Jan;26(1):34-8. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2008. PMID: 18302890 Chinese.
-
Association of CEA, NSE, CYFRA 21-1, SCC-Ag, and ProGRP with Clinicopathological Characteristics and Chemotherapeutic Outcomes of Lung Cancer.Lab Med. 2023 Jul 5;54(4):372-379. doi: 10.1093/labmed/lmac122. Lab Med. 2023. PMID: 36282321
-
Left Lung Neoplasms and Bilateral Pleural Effusion Combined Elevated Carcinoembryonic Antigen in Pleural Effusion with Negative Result of Thoracoscopy Pleural Biopsy Misdiagnosed as Lung Carcinoma Ultimately Confirmed Pulmonary Sarcomatoid Carcinoma by CT-guided Percutaneous Lung Biopsy: a Case Report and Literature Review.Clin Lab. 2019 Aug 1;65(8). doi: 10.7754/Clin.Lab.2019.190127. Clin Lab. 2019. PMID: 31414757 Review.
-
[Usefulness and limitation of serum tumor markers in diagnosis of lung cancer].Nihon Rinsho. 1996 Jun;54(6):1610-5. Nihon Rinsho. 1996. PMID: 8691617 Review. Japanese.
Cited by
-
Bronchoalveolar lavage fluid assessment facilitates precision medicine for lung cancer.Cancer Biol Med. 2023 Dec 29;21(3):230-51. doi: 10.20892/j.issn.2095-3941.2023.0381. Cancer Biol Med. 2023. PMID: 38164737 Free PMC article. Review.
-
Correlations between iodine uptake, invasive CT features and pleural invasion in adenocarcinomas with pleural contact.Sci Rep. 2023 Sep 27;13(1):16191. doi: 10.1038/s41598-023-43504-0. Sci Rep. 2023. PMID: 37758831 Free PMC article.
-
Retracted: Detection of CEA and ProGRP Levels in BALF of Patients with Peripheral Lung Cancer and Their Relationship with CT Signs.Biomed Res Int. 2023 Dec 29;2023:9810949. doi: 10.1155/2023/9810949. eCollection 2023. Biomed Res Int. 2023. PMID: 38188794 Free PMC article.
-
Emerging Biosensing Methods to Monitor Lung Cancer Biomarkers in Biological Samples: A Comprehensive Review.Cancers (Basel). 2023 Jun 29;15(13):3414. doi: 10.3390/cancers15133414. Cancers (Basel). 2023. PMID: 37444523 Free PMC article. Review.
-
Habitat-based radiomics from contrast-enhanced CT and clinical data to predict lymph node metastasis in clinical N0 peripheral lung adenocarcinoma ≤ 3 cm.Sci Rep. 2025 May 16;15(1):17085. doi: 10.1038/s41598-025-02181-x. Sci Rep. 2025. PMID: 40379768 Free PMC article.
References
-
- Li Y., Tang M., Huang L.-L., et al. Ginsenoside 3β-O-Glc-DM (C3DM) enhances the antitumor activity of Taxol on Lewis lung cancer by targeting the interleukin-6/Jak2/STAT3 and interleukin-6/AKT signaling pathways. World Journal of Traditional Chinese Medicine . 2020;6(4):432–440. doi: 10.4103/wjtcm.wjtcm_51_20. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical